{"lastClose": 5.610000133514404, "len": 1112, "date": "2023-03-14", "alpha_1": -0.3057254290313056, "beta_1": 1.6300109708450565, "drawup_1": 1.5486725887776869, "natr_1": 15.181813325600254, "sup_1": -0.314913876496459, "res_1": 0.430778333370024, "bullPattern_1": [], "bearPattern_1": ["ENGULFING", "SHORTLINE"], "rsi_1": 27.99999455043099, "adx_1": 35.62370578369239, "drawdown_1": -0.6753472273962363, "stratHoldSharpe_1": -0.04413597118034856, "stratHoldAlpha_1": 250.96913133608047, "stratHoldDrawdown_1": -0.6436845065817596, "alpha_3mo": -0.028247321789788837, "beta_3mo": 2.0220251233498883, "drawup_3mo": 0.4608541290620036, "natr_3mo": 15.181813325600254, "sup_3mo": -0.004753383539213472, "res_3mo": 0.22043965971563897, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 16.363638990838943, "adx_3mo": 17.138145985520943, "drawdown_3mo": -0.3166869540258124, "stratHoldSharpe_3mo": -1.2208551137977794, "stratHoldAlpha_3mo": 250.284376800236, "stratHoldDrawdown_3mo": -0.28899591286307125, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "Market Cap": 809018964, "IPO Year": 2018.0, "alpha%_1": 0.2034213173936596, "beta%_1": 0.9015762214144922, "drawup%_1": 0.9971947473140568, "natr%_1": 0.9999920538923176, "drawdown%_1": 0.06250902979337858, "stratHoldSharpe%_1": 0.4357863714370642, "stratHoldAlpha%_1": 0.4061922263385333, "stratHoldDrawdown%_1": 0.048234104131866344, "alpha%_3mo": 0.2997726417288889, "beta%_3mo": 0.9653059008361289, "drawup%_3mo": 0.8932546779876517, "natr%_3mo": 0.9999897155168007, "drawdown%_3mo": 0.07316558278398107, "stratHoldSharpe%_3mo": 0.20080215773548693, "stratHoldAlpha%_3mo": 0.09017986261662025, "stratHoldDrawdown%_3mo": 0.07494864572891763}